Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Argus Health
Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Federal Trade Commission

Generated: December 10, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,886,789

« Back to Dashboard

Summary for Patent: 4,886,789

Title: Peritoneal dialysis and compositions for use therein
Abstract:A peritoneal dialysis composition containing an osmotic agent comprising a glucose polymer mixture, said mixture including at least 15% by weight of glucose polymers having a D.P. (degree of polymerization) greater than 12. A method is provided for preparing the glucose polymers and a defined sterile aqueous solution of the same for use in peritoneal dialysis by introduction into the abdominal cavity. Also disclosed are methods of treating toxaemia caused by toxins arising from internal disorders of the body, such as hepatic encephalopathy, or which arise from external sources such as poisoning by overdoses of drugs or industrial and agricultural chemicals, e.g., paraquat.
Inventor(s): Milner; Jeremiah (Roscrea, IE)
Assignee: M. L. Laboratories PLC (London, GB2)
Application Number:07/335,778
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,886,789

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8300718Jan 12, 1983
United Kingdom8404299Feb 18, 1984

International Patent Family for Patent: 4,886,789

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria38778► Subscribe
Austria53765► Subscribe
Australia3863085► Subscribe
Australia584603► Subscribe
Canada1253076► Subscribe
Germany3475270► Subscribe
Germany3577402► Subscribe
Denmark169859► Subscribe
Denmark58185► Subscribe
European Patent Office0115911► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Queensland Health
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: